Celadon Group (Nasdaq: CLDN) announced it has launched two new clinical development initiatives for MYDICAR, its lead product candidate, in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE